Related Experiment Video

Updated: Jun 8, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Meningococcal meningitis

Ricardo G Branco1, Robert C Tasker

  • 1School of Clinical Medicine, Department of Paediatrics, Addenbrookes Hospital, University of Cambridge, Box 116, Hills Road, Cambridge, CB2 2QQ, UK, rgb35@cam.ac.uk.

Current Treatment Options in Neurology
|September 16, 2010
PubMed
Abstract

Insights

Early recognition and treatment of meningococcal meningitis (MM) with shock are crucial. Prompt antibiotics are vital, with low-dose steroids recommended for refractory shock to improve patient outcomes.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Neurology

Background:

  • Meningococcal meningitis (MM) is a significant global cause of illness and death.
  • MM with shock necessitates immediate medical intervention.
  • Timely management is key to reducing morbidity and mortality.

Purpose of the Study:

  • To outline essential management strategies for meningococcal meningitis (MM).
  • To emphasize the critical importance of early shock recognition and treatment in MM.
  • To provide guidance on managing complications and adjunctive therapies.

Main Methods:

  • This opinion statement synthesizes current clinical knowledge and expert consensus.
  • It focuses on established and emerging treatment protocols for MM.
  • Evidence-based recommendations are provided for clinical practice.

Main Results:

  • Immediate antibiotic administration is paramount upon suspicion of MM.
  • Low-dose corticosteroids are recommended for meningococcal disease with refractory shock.
  • Management of intracranial pressure and seizures is critical in severe MM cases.

Conclusions:

  • Prompt initiation of antibiotics and appropriate management of shock are essential for improving outcomes in MM.
  • Careful consideration of cerebral edema and intracranial pressure is necessary.
  • Certain treatments like mannitol and activated protein C should be avoided, while neuroprotection strategies warrant further research.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.